Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

被引：1
|
作者：
Akazawa, Yu
Hosono, Ako
Yoshikawa, Toshiaki
Kaneda, Hide
Hara, Junichi
Kinoshita, Yoshiaki
Kohashi, Kenichi
Manabe, Atsushi
Shioda, Yoko
Shoda, Kayoko
Shimomura, Manami
Mizuno, Shoichi
Nakamoto, Yasunari
Nakatsura, Tetsuya
机构：
[1] Natl Canc Ctr, Kashiwa, Chiba, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Osaka City Gen Hosp, Osaka, Japan
[4] Kyushu Univ Hosp, Fukuoka, Japan
[5] St Lukes Int Hosp, Tokyo, Japan
[6] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[7] Univ Fukui, Fukui, Japan
来源：
CANCER IMMUNOLOGY RESEARCH | 2019年 / 7卷 / 02期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR18-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：2
相关论文
共 50 条
  • [21] A PHASE I STUDY ON CABOZANTINIB MONOTHERAPY IN PEDIATRIC PATIENTS WITH RECURRENT AND/OR REFRACTORY SOLID TUMORS (CAMEL STUDY)
    Nakajima, Miho
    Tao, Kayoko
    Kimura, Toshimi
    Ogawa, Chitose
    Arakawa, Ayumu
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [22] PHASE I STUDY OF CABAZITAXEL IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY SOLID TUMORS: A POETIC GROUP STUDY
    Manley, P.
    Trippett, T.
    Smith, A.
    Macy, M.
    Leary, S.
    Boklan, J.
    Cohen, K.
    Shen, L.
    Herzog, C.
    Veyrat-Follet, C.
    Zhang, J.
    Chi, S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S157 - S158
  • [23] A PHASE I STUDY OF VINBLASTINE AND SIROLIMUS IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS INCLUDING CNS TUMORS
    Marzouki, Monia
    Bartels, Ute
    Gammon, Janet
    Bergendahl, Genevieve
    Yankanah, Rosanna
    Wu, Bing
    Samson, Yvan
    Sholler, Giselle
    Irwin, Meredith S.
    Baruchel, Sylvain
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1091 - 1091
  • [24] A PHASE-I STUDY OF SULOFENUR IN REFRACTORY PEDIATRIC MALIGNANT SOLID TUMORS
    PRATT, CB
    BOWMAN, LC
    MARINA, N
    PAPPO, A
    AVERY, L
    LUO, XL
    MEYER, WH
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (01) : 63 - 66
  • [25] Phase I study of fotemustine in pediatric patients with refractory brain tumors
    Hargrave, DR
    Bouffet, E
    Gammon, J
    Tariq, N
    Grant, RM
    Baruchel, S
    CANCER, 2002, 95 (06) : 1294 - 1301
  • [26] First in Children Phase I Clinical Study of Oral Olaparib in Pediatric Patients with Refractory Solid Tumors
    Takagi, M.
    Ogawa, C.
    Iehara, T.
    Aoki-Nogami, Y.
    Isibashi, E.
    Imai, M.
    Kimura, T.
    Nagata, M.
    Yasuhara, M.
    Masutani, M.
    Yoshimura, K.
    Tomizawa, D.
    Ogawa, A.
    Yonemori, K.
    Kihara, T.
    Nobori, K.
    Hasebe, K.
    Mizutani, S.
    Morio, T.
    Hosoi, H.
    Koike, R.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S85 - S86
  • [27] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Chika Nitani
    Junichi Hara
    Hiroshi Kawamoto
    Tomoaki Taguchi
    Toshimi Kimura
    Kenichi Yoshimura
    Akinobu Hamada
    Shigehisa Kitano
    Naoko Hattori
    Toshikazu Ushijima
    Hiromi Ono
    Masako Nakamoto
    Tsukiko Higuchi
    Akihiro Sato
    Cancer Chemotherapy and Pharmacology, 2021, 88 : 99 - 107
  • [28] Phase I study of tamibarotene monotherapy in pediatric and young adult patients with recurrent/refractory solid tumors
    Nitani, Chika
    Hara, Junichi
    Kawamoto, Hiroshi
    Taguchi, Tomoaki
    Kimura, Toshimi
    Yoshimura, Kenichi
    Hamada, Akinobu
    Kitano, Shigehisa
    Hattori, Naoko
    Ushijima, Toshikazu
    Ono, Hiromi
    Nakamoto, Masako
    Higuchi, Tsukiko
    Sato, Akihiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 88 (01) : 99 - 107
  • [29] First in Children Phase I Clinical Study of Oral Olaparib in Pediatric Patients with Refractory Solid Tumors
    Takagi, Masatoshi
    Ogawa, Chitose
    Iehara, Tomoko
    Nogami, Yuki
    Tomizawa, Daisuke
    Ogawa, Atsushi
    Takita, Junko
    Mizutani, Shuki
    Morio, Tomohiro
    Hosoi, Hajime
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [30] A phase I study of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors.
    McGregor, L. M.
    Spunt, S. L.
    Ward, D.
    Wu, J.
    Billups, C.
    Ivy, S. P.
    Santana, V. M.
    Fouladi, M.
    Furman, W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345